ibr 280 (Imbruvica 280 mg)
Generic Name: ibrutinib
Pill with imprint ibr 280 is Purple, Elliptical/Oval and has been identified as Imbruvica 280 mg. It is supplied by Pharmacyclics, Inc.
Imbruvica is used in the treatment of chronic lymphocytic leukemia; waldenström macroglobulinemia; mantle cell lymphoma; non-hodgkin's lymphoma; lymphoma and belongs to the drug class BTK inhibitors. There is positive evidence of human fetal risk during pregnancy. Imbruvica 280 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for ibr 280
Imbruvica
- Generic Name
- ibrutinib
- Imprint
- ibr 280
- Strength
- 280 mg
- Color
- Purple
- Size
- 15.00 mm
- Shape
- Elliptical/Oval
- Availability
- Prescription only
- Drug Class
- BTK inhibitors
- Pregnancy Category
- D - Positive evidence of risk
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Pharmacyclics, Inc.
- National Drug Code (NDC)
- 57962-0280
More about Imbruvica (ibrutinib)
- Side effects
- Drug interactions
- Dosage information
- During pregnancy or Breastfeeding
- Reviews (45)
- Patient tips
- Drug images
- Compare alternatives
- Pricing & coupons
- En español
- Drug class: BTK inhibitors
- FDA approval history
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.